2022
The Prognostic Value of CAC Zero Among Individuals Presenting With Chest Pain A Meta-Analysis
Agha AM, Pacor J, Grandhi GR, Mszar R, Khan SU, Parikh R, Agrawal T, Burt J, Blankstein R, Blaha MJ, Shaw LJ, Al-Mallah MH, Brackett A, Cainzos-Achirica M, Miller EJ, Nasir K. The Prognostic Value of CAC Zero Among Individuals Presenting With Chest Pain A Meta-Analysis. JACC Cardiovascular Imaging 2022, 15: 1745-1757. PMID: 36202453, DOI: 10.1016/j.jcmg.2022.03.031.Peer-Reviewed Original ResearchConceptsObstructive coronary artery diseaseAcute chest painCoronary artery calciumCoronary artery diseaseStable chest painNonobstructive coronary artery diseaseMajor adverse cardiac eventsAdverse cardiac eventsChest painCardiac eventsLow prevalenceAbsence of CACHealth care delivery modelsCare delivery modelsA Meta-AnalysisNegative predictive valueCAC assessmentArtery calciumCAC scoreIntermediate riskArtery diseaseCoronary CTACTA assessmentPrognostic valueTomography angiography
2021
Alternate accesses for transcatheter aortic valve replacement: A network meta‐analysis
Hameed I, Oakley CT, Hameed NUF, Ahmed A, Naeem N, Singh S, Rizwana K, Brackett A, Forrest JK, Kaple R, Mangi A, Salemi A, Geirsson A, Gaudino M, Vallabhajosyula P. Alternate accesses for transcatheter aortic valve replacement: A network meta‐analysis. Journal Of Cardiac Surgery 2021, 36: 4308-4319. PMID: 34494307, DOI: 10.1111/jocs.15961.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementAortic valve replacementTF accessValve replacementHigher long-term mortalityLong-term strokeSuperior postoperative outcomesLong-term mortalityRandom-effects networkComprehensive literature searchDifferent treatment groupsPostoperative outcomesTransfemoral accessRandomized trialsTA accessTranscarotidTreatment groupsTransapicalLiterature searchTC accessCombination of TFSignificant differencesStrokeProbability rankMortality
2020
Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis
Klemen ND, Feingold PL, Hashimoto B, Wang M, Kleyman S, Brackett A, Gross CP, Pei KY. Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis. The Lancet Haematology 2020, 7: e583-e593. PMID: 32735837, DOI: 10.1016/s2352-3026(20)30211-8.Peer-Reviewed Original ResearchMeSH KeywordsBayes TheoremHumansPrognosisRandomized Controlled Trials as TopicRisk FactorsSurvival RateVenous ThromboembolismConceptsVenous thromboembolism preventionFatal pulmonary embolismPulmonary embolismVenous thromboembolismThromboembolism preventionMajor bleedingRisk ratioMortality riskTreatment groupsControl groupSystematic reviewLess major bleedingMedian risk ratioMore pulmonary embolismDe-escalation trialsVenous thromboembolism riskStudy of patientsActive control agentWeb of ScienceAntiplatelet therapyEligible RCTsPrimary endpointSecondary endpointsComposite endpointOverall mortalityRevascularization Options for Females With Multivessel Coronary Artery Disease A Meta-Analysis of Randomized Controlled Trials
Gul B, Shah T, Head SJ, Chieffo A, Hu X, Li F, Brackett A, Gesick C, Bisarya PK, Lansky A. Revascularization Options for Females With Multivessel Coronary Artery Disease A Meta-Analysis of Randomized Controlled Trials. JACC Cardiovascular Interventions 2020, 13: 1009-1010. PMID: 32113933, DOI: 10.1016/j.jcin.2019.12.036.Peer-Reviewed Original Research